The New York Stock Exchange ended in scattered order not far from equilibrium on Monday, during a session without macroeconomic news, awaiting crucial statistics on inflation from Wednesday.
According to final results, the Dow Jones index climbed 0.09% to 32,832.54 points, the Nasdaq lost 0.10% to 12,644.46 points and the S&P 500 0.12% to 4,140.06 points.
“It was a mixed session as the Nasdaq divergence was driven by disappointing results from microprocessor maker Nvidia, said Peter Cardillo of Spartan Capital.
In the absence of macro-economic news, the markets reacted to several corporate earnings announcements.
On the Nasdaq, the graphics card maker, Nvidia, dropped 6.30% to 177.93 dollars and said it was “surprised” by the drop in revenue from video games.
The group announced preliminary results for the second quarter which show a “significant slowdown in the video game side”.
Also on the Nasdaq, the American data analysis firm Palantir fell 14.24% to 9.82 dollars after larger than expected losses in the second quarter, notably weighed down by unfavorable exchange rates.
The American pharmaceutical group Pfizer rose 0.61% to 49.57 dollars after the announcement of the acquisition for approximately 5.4 billion dollars of Global Blood Therapeutics (GBT), maker of a drug recently approved against a genetic disease , sickle cell disease.
While GBT’s purchase price was set at $68.50 a share, its stock rose 4.32% to $66.60.
Markets remained on the lookout for CPI inflation indices on Wednesday and expected producer prices on Thursday as they could set the tone for the Federal Reserve’s (Fed) attitude ahead.
Projections bet on a slowdown in price increases to +0.2% over the month against +1.3% in June and 9.1% over one year, which could finally suggest that inflation has reached a peak .
Bond yields seemed to think so as they eased to 2.74% from 2.82% on Friday for ten-year Treasuries.
“Bond yields are falling. On Wednesday, we have the CPI index, if we have a little respite on this side, the market could go up”, predicted Peter Cardillo.
The green light expected from the air regulatory authority so that Boeing can resume delivery of its 787 Dreamliner has hardly moved the action of the aircraft manufacturer (+0.52% to 165.89 dollars).
Speculative stock in struggling home goods chain Bed Bath and Beyond jumped 39.83% to $11.41.